BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8971539)

  • 1. Correlation between tumour and serum beta 2m expression in patients with breast cancer.
    Klein T; Levin I; Niska A; Koren R; Gal R; Schachter J; Kfir B; Narinski R; Warchaizer S; Klein B
    Eur J Immunogenet; 1996 Dec; 23(6):417-23. PubMed ID: 8971539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.
    Wintzer HO; Benzing M; von Kleist S
    Br J Cancer; 1990 Aug; 62(2):289-95. PubMed ID: 2201398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.
    Feinmesser M; Sulkes A; Morgenstern S; Sulkes J; Stern S; Okon E
    J Clin Pathol; 2000 Apr; 53(4):286-91. PubMed ID: 10823125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble histocompatibility antigen class I in breast cancer patients in relation to tumor burden.
    Klein B; Klein T; Figer A; Bleiberg M; Shapira J; Loven D; Livni E; Lurie H; Niska A
    Cancer; 1991 May; 67(9):2295-9. PubMed ID: 2013037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin in squamous cell carcinomas of the head and neck and in tumours heterotransplanted into nude athymic mice.
    Wennerberg J; Alm P; Lögdberg L; Tropé C
    Acta Otolaryngol; 1984; 98(3-4):335-42. PubMed ID: 6388230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of beta-2 microglobulin in temperature-sensitive and interferon-gamma-induced exocytosis of HLA class I molecules.
    Tatake RJ; Ferrone S; Zeff RA
    Transplantation; 1992 Sep; 54(3):395-403. PubMed ID: 1412716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of mammary serum antigen (MSA) with beta 2-microglobulin (beta 2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer.
    Tjandra JJ; McLaughlin PJ; Russell IS; Collins JP; McKenzie IF
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1633-40. PubMed ID: 3061824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of beta 2m-free HLA class I heavy chains in neuroblastoma cell lines.
    Marozzi A; Meneveri R; Bunone G; De Santis C; Lopalco L; Beretta A; Agresti A; Siccardi AG; Della Valle G; Ginelli E
    Scand J Immunol; 1993 Jun; 37(6):661-7. PubMed ID: 8316764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total loss of MHC class I is an independent indicator of good prognosis in breast cancer.
    Madjd Z; Spendlove I; Pinder SE; Ellis IO; Durrant LG
    Int J Cancer; 2005 Nov; 117(2):248-55. PubMed ID: 15900607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MHC class I associated beta 2-microglobulin (beta 2m) light chain is expressed in a molar excess over HLA-ABC and CD1 on the membrane of leukaemic B cells but not leukaemic T cells: evidence for further beta 2m-associated molecules.
    Jones RA; Child JA; Master PS; Scott CS
    Scand J Immunol; 1991 Jul; 34(1):53-61. PubMed ID: 1712510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
    Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P
    Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular comparisons of the beta 2-microglobulin-binding site in class I major-histocompatibility-complex alpha-chains and proteins of related sequences.
    Tysoe-Calnon VA; Grundy JE; Perkins SJ
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):359-69. PubMed ID: 1859364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.
    Bhan AK; DesMarais CL
    J Natl Cancer Inst; 1983 Sep; 71(3):507-16. PubMed ID: 6193308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex status in breast carcinogenesis and relationship to apoptosis.
    Redondo M; García J; Villar E; Rodrigo I; Perea-Milla E; Serrano A; Morell M
    Hum Pathol; 2003 Dec; 34(12):1283-9. PubMed ID: 14691914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of MHC class I and class I-like gene products on the cell membrane of mature and immature T cells.
    Jones RA; Scott CS; Child JA
    Leuk Res; 1988; 12(10):799-804. PubMed ID: 3059069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of cell surface MHC class I heavy and light chain molecules in pre-malignant and malignant lesions of the oral mucosa.
    Prime SS; Pitigala-Arachchi A; Crane IJ; Rosser TJ; Scully C
    Histopathology; 1987 Jan; 11(1):81-91. PubMed ID: 3549515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of soluble HLA class I heterodimers and beta 2-microglobulin in patients with active pulmonary tuberculosis.
    Inostroza J; Muñoz P; Espinoza R; Millaqueo L; Diaz P; Leiva L; Sorensen R
    Hum Immunol; 1994 Jul; 40(3):179-82. PubMed ID: 7960960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.
    Goepel JR; Rees RC; Rogers K; Stoddard CJ; Thomas WE; Shepherd L
    Br J Cancer; 1991 Nov; 64(5):880-3. PubMed ID: 1718386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 2 microglobulin on the envelope of urinary cytomegalovirus is not associated with host class I human leukocyte antigen alpha chain.
    Rose JS; Grundy JE
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():507-12. PubMed ID: 1372035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
    Glas R; Ohlén C; Höglund P; Kärre K
    J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.